89bio (ETNB)
NASDAQ:ETNB
US Market
Holding ETNB?
Track your performance easily

89bio (ETNB) Income Statement

776 Followers

89bio Income Statement

Last quarter (Q3 2024), 89bio's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, 89bio's net income was $-149.07M. See 89bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
------
Cost of Revenue
------
Gross Profit
------
Operating Expense
$ 303.86M$ 151.20M$ 102.25M$ 89.74M$ 49.35M$ 26.64M
Operating Income
$ -303.86M$ -151.20M$ -102.25M$ -89.74M$ -49.35M$ -26.64M
Net Non Operating Interest Income Expense
$ -13.05M$ -12.88M$ -242.00K$ -526.00K--
Other Income Expense
$ -24.16M$ -17.68M$ -2.16M$ -219.00K$ 203.00K$ 30.56M
Pretax Income
$ -284.66M$ -138.32M$ -102.01M$ -90.27M$ -49.56M$ -57.20M
Tax Provision
$ 4.30M$ 3.87M$ 19.00K$ -147.00K$ -59.00K$ 218.00K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -288.96M$ -142.19M$ -102.03M$ -90.12M$ -49.50M$ -57.42M
Basic EPS
$ -2.90$ -2.00$ -2.93$ -4.48$ -3.08-
Diluted EPS
$ -2.90$ -2.00$ -2.93$ -4.48$ -3.08$ 24.49
Basic Average Shares
$ 383.81M$ 71.17M$ 34.81M$ 20.10M$ 16.09M$ 2.34M
Diluted Average Shares
$ 383.81M$ 71.17M$ 34.81M$ 20.10M$ 16.09M$ 2.34M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 303.86M$ 151.20M$ 102.25M$ 89.74M$ 49.35M$ 26.64M
Net Income From Continuing And Discontinued Operation
$ -288.96M$ -142.19M$ -102.03M$ -90.12M$ -49.50M$ -57.42M
Normalized Income
$ -194.74M-----
Interest Expense
------
EBIT
$ -279.69M$ -133.53M$ -100.08M$ -89.59M$ -49.35M$ -57.20M
EBITDA
$ -276.13M$ -133.48M$ -100.02M$ -89.52M$ -49.30M$ -57.19M
Currency in USD

89bio Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis